WEBSITE BSE:537291 NSE: NATH BIOGEN Inc. Year: 2000 Industry: Agriculture
Last updated: 15:57
Nath Bio-Genes (India) Ltd engages inside the production, processing, and advertising of hybrid and GM seeds in India and the world over. It operates in segments, Agricultural Activities and Trading Activities. The company gives seeds for cereals, which include maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, consisting of cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green peas, pum...Read More
Nath Bio-Genes (India) Ltd engages inside the production, processing, and advertising of hybrid and GM seeds in India and the world over. It operates in segments, Agricultural Activities and Trading Activities. The company gives seeds for cereals, which include maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, consisting of cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green peas, pumpkin, tinda, cabbage, and French beans. It also gives crop protection supplements, along with WINPro GOLii, WINall, and Win Chi Win boom enhancer; and forage supplements, consisting of NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The organisation offers its merchandise through a network of distributors, sellers, and processing plants. Nath Bio-Genes (India) Ltd became founded in 1979 and is primarily based in Aurangabad, India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹270 Cr.
Stock P/E 7
P/B 0.4
Current Price ₹142.1
Book Value ₹ 357.7
Face Value 10
52W High ₹238
Dividend Yield 1.41%
52W Low ₹ 138
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 235 | 23 | 32 | 43 | 244 | 32 | 37 | 52 | 284 | 44 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 2 |
| Total Income | 235 | 23 | 32 | 43 | 244 | 32 | 37 | 56 | 285 | 46 |
| Total Expenditure | 198 | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 245 | 38 |
| Operating Profit | 37 | 5 | 6 | 4 | 37 | 5 | 9 | 4 | 40 | 8 |
| Interest | 3 | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 33 | 2 | 5 | 2 | 34 | 1 | 4 | 2 | 36 | 3 |
| Provision for Tax | 0 | 0 | 1 | 1 | 0 | -0 | 1 | 1 | 1 | 1 |
| Profit After Tax | 33 | 2 | 4 | 2 | 33 | 1 | 3 | 1 | 35 | 3 |
| Adjustments | 0 | 0 | 0 | 1 | 0 | -0 | 0 | 1 | 2 | 0 |
| Profit After Adjustments | 33 | 2 | 4 | 3 | 33 | 1 | 3 | 1 | 37 | 3 |
| Adjusted Earnings Per Share | 17.5 | 0.8 | 2 | 1.4 | 17.6 | 0.6 | 1.4 | 0.8 | 19.6 | 1.4 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Net Sales | 124 | 138 | 278 | 301 | 333 | 365 | 417 |
| Other Income | 1 | 1 | 2 | 1 | 1 | 5 | 8 |
| Total Income | 125 | 138 | 280 | 302 | 333 | 369 | 424 |
| Total Expenditure | 109 | 118 | 241 | 252 | 283 | 315 | 364 |
| Operating Profit | 16 | 20 | 39 | 50 | 51 | 55 | 61 |
| Interest | 2 | 4 | 11 | 10 | 9 | 11 | 12 |
| Depreciation | 5 | 5 | 3 | 3 | 3 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | -89 | 0 | 3 | 1 | 0 |
| Profit Before Tax | 9 | 12 | -63 | 36 | 42 | 41 | 45 |
| Provision for Tax | -0 | 1 | 4 | 1 | 2 | 2 | 4 |
| Profit After Tax | 9 | 12 | -67 | 35 | 40 | 39 | 42 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Profit After Adjustments | 9 | 12 | -67 | 35 | 40 | 39 | 44 |
| Adjusted Earnings Per Share | 0 | 0 | -35.5 | 18.4 | 20.8 | 20.3 | 23.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 10% | 10% | 24% | 0% |
| Operating Profit CAGR | 8% | 12% | 28% | 0% |
| PAT CAGR | -3% | 0% | 34% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -19% | -4% | -13% | 5% |
| ROE Average | 6% | 6% | 4% | 7% |
| ROCE Average | 7% | 7% | 6% | 8% |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Shareholder's Funds | 46 | 57 | 542 | 573 | 610 | 644 |
| Minority's Interest | 0 | 0 | -0 | 0 | 0 | 0 |
| Borrowings | 1 | 1 | 1 | 0 | 5 | 13 |
| Other Non-Current Liabilities | 1 | 1 | 3 | 3 | 3 | 4 |
| Total Current Liabilities | 72 | 98 | 194 | 216 | 262 | 365 |
| Total Liabilities | 119 | 157 | 739 | 793 | 880 | 1026 |
| Fixed Assets | 21 | 38 | 245 | 244 | 249 | 250 |
| Other Non-Current Assets | 2 | 0 | 27 | 29 | 59 | 86 |
| Total Current Assets | 96 | 120 | 468 | 520 | 572 | 690 |
| Total Assets | 119 | 157 | 739 | 793 | 880 | 1026 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 3 | 29 | 4 | 38 | 77 |
| Cash Flow from Operating Activities | 0 | 14 | 17 | 38 | 75 | 18 |
| Cash Flow from Investing Activities | 0 | -21 | -20 | -3 | -27 | -4 |
| Cash Flow from Financing Activities | 0 | 6 | -22 | -2 | -8 | -2 |
| Net Cash Inflow / Outflow | 0 | -1 | -25 | 34 | 39 | 11 |
| Closing Cash & Cash Equivalent | 0 | 2 | 4 | 38 | 77 | 89 |
| # | Mar 2012 | Mar 2013 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0 | 0 | -35.46 | 18.43 | 20.85 | 20.31 |
| CEPS(Rs) | 8.69 | 10.16 | -33.84 | 20.01 | 22.56 | 22.32 |
| DPS(Rs) | 0 | 0 | 2 | 2 | 2 | 2 |
| Book NAV/Share(Rs) | 0 | 0 | 285.16 | 301.61 | 320.94 | 339.08 |
| Core EBITDA Margin(%) | 11.84 | 14.45 | 13.37 | 16.25 | 15.02 | 13.69 |
| EBIT Margin(%) | 8.78 | 11.6 | -18.96 | 15.44 | 15.26 | 14.04 |
| Pre Tax Margin(%) | 7.32 | 8.93 | -22.79 | 12 | 12.5 | 11.12 |
| PAT Margin (%) | 7.42 | 8.53 | -24.21 | 11.62 | 11.91 | 10.58 |
| Cash Profit Margin (%) | 11.22 | 11.8 | -23.1 | 12.62 | 12.89 | 11.62 |
| ROA(%) | 7.73 | 8.5 | -15.03 | 4.57 | 4.74 | 4.05 |
| ROE(%) | 20.12 | 22.76 | -22.48 | 6.28 | 6.7 | 6.15 |
| ROCE(%) | 19.09 | 23.88 | -14.84 | 7.09 | 7.26 | 6.89 |
| Receivable days | 36.68 | 44.32 | 69.85 | 110.74 | 105.14 | 91.63 |
| Inventory Days | 193.69 | 189.43 | 195.06 | 259.3 | 240.4 | 284.23 |
| Payable days | 1576.65 | -4219.16 | 1503.38 | 744.29 | -1457.17 | -249 |
| PER(x) | 0 | 0 | 0 | 7.69 | 8.33 | 7.18 |
| Price/Book(x) | 0 | 0 | 0.75 | 0.47 | 0.54 | 0.43 |
| Dividend Yield(%) | 0 | 0 | 0.94 | 1.41 | 1.15 | 1.37 |
| EV/Net Sales(x) | 0.19 | 0.24 | 1.78 | 1.12 | 1.09 | 0.85 |
| EV/Core EBITDA(x) | 1.54 | 1.6 | 12.65 | 6.79 | 7.18 | 5.7 |
| Net Sales Growth(%) | 0 | 11.13 | 102.15 | 8.26 | 10.37 | 9.71 |
| EBIT Growth(%) | 0 | 46.76 | -430.58 | 188.13 | 9.13 | 0.91 |
| PAT Growth(%) | 0 | 27.66 | -673.7 | 151.96 | 13.16 | -2.57 |
| EPS Growth(%) | 0 | 0 | -583.1 | 151.98 | 13.11 | -2.57 |
| Debt/Equity(x) | 0.25 | 0.33 | 0.17 | 0.18 | 0.18 | 0.19 |
| Current Ratio(x) | 1.34 | 1.22 | 2.41 | 2.4 | 2.18 | 1.89 |
| Quick Ratio(x) | 0.42 | 0.43 | 1.27 | 1.44 | 1.3 | 0.96 |
| Interest Cover(x) | 6.02 | 4.35 | -4.96 | 4.49 | 5.52 | 4.81 |
| Total Debt/Mcap(x) | 0 | 0 | 0.23 | 0.39 | 0.33 | 0.44 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 | 45.6 |
| FII | 0.22 | 0.32 | 0.27 | 0.21 | 0.18 | 0.19 | 0.21 | 0.41 | 0.32 | 0.31 |
| DII | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 3.95 | 2.25 | 0.76 | 0.01 |
| Public | 49.81 | 49.72 | 49.76 | 49.82 | 49.85 | 49.84 | 50.25 | 51.74 | 53.32 | 54.08 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
| FII | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 |
| DII | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.04 | 0.01 | 0 |
| Public | 0.95 | 0.94 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.98 | 1.01 | 1.03 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
